|
|
|
[回顾性研究]
肺癌：微波治疗回顾性研究
日期：2020-03-03 22:53:15
点击：198
好评：0
研究的设计和分析 Primary endpoints Duration of patient follow-up (date of ablation to last known chest CT or PET/CT) Primary and secondary technical success rate Time to first recurrence/local control rate All-cause and cancer specific mort...
[技术成功率/失败率]
肺癌微波消融：技术成功
日期：2020-03-02 21:32:34
点击：115
好评：0
Primary technical success Complete lack of enhancement in the ablation zone at 1 month follow up Thin (5 mm), symmetric rim of enhancement considered benign Nodular enhancement ( 15 HU) at the ablation site considered residual tumor and te...
[mRECIST]
肺癌微波治疗：mRECIST疗效判定
日期：2020-03-01 23:45:09
点击：80
好评：0
Evaluating Response mRECIST（肺癌的mRECIST标准） 注意此标准和肝癌TACE的mRECIST标准的不同 Complete response (CR) was where the target lesion demonstrated cavitations, necrosis and cyst formation with a 25% reduction in size Partial response...